787541-88-2 Usage
Uses
Used in Pharmaceutical Development:
2-methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry Research:
2-methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine serves as a valuable research tool in medicinal chemistry, where it can be used to explore the structure-activity relationships of bioactive molecules. Its heterocyclic nature and specific functional groups make it an interesting molecule for further study and potential therapeutic use.
Used in Drug Design:
2-methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine is employed as a building block in drug design, where its incorporation into molecular frameworks can lead to the discovery of novel bioactive compounds with improved pharmacological properties.
Used in Bioactive Compounds Synthesis:
In the synthesis of bioactive compounds, 2-methyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine is used as a versatile starting material. Its presence in the molecular structure can enhance the biological activity and selectivity of the resulting compounds, making it a valuable component in the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 787541-88-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,7,5,4 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 787541-88:
(8*7)+(7*8)+(6*7)+(5*5)+(4*4)+(3*1)+(2*8)+(1*8)=222
222 % 10 = 2
So 787541-88-2 is a valid CAS Registry Number.
787541-88-2Relevant academic research and scientific papers
AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 33-34, (2010/11/28)
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 38, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme (""DPP-IV inhibitors"") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
